Oncology Cosmeceutical Solutions
For Skin-Related Treatment Toxicities
At Wembrace Biopharma, a trusted name among evolving oncology pharma companies, we focus on supportive care innovations that help patients manage the visible and uncomfortable side effects of cancer therapy. Our specialized cosmeceutical oncology products are designed to address treatment-related skin toxicities, including IRguard for radiation-induced dermatitis and Hafoguard for chemotherapy-associated Hand-Foot Syndrome (HFS). Backed by science and patient-centric formulation, these solutions reinforce Wembrace’s position among progressive oncology drug companies and cancer pharmaceutical companies dedicated to preserving skin integrity, comfort, and quality of life during cancer treatment.
| Brand Name | Molecule | Therapy | Dosage Form | Packing | Description |
|---|---|---|---|---|---|
| HAFOGUARD 50GM | 20% Urea + Pentavitin | Onco-Cosmeceuticals | Cream | 1X50 GM | 100% natural, plant-based cream for managing chemotherapy-induced Hand and Foot Syndrome (HFS). Hafoguard is a unique formulation with 20% Urea and Pentavitin. It is paraben-free and non-greasy. Restores skin barrier function, reduces water loss, and provides safe, effective comfort. |
| IRGUARD 50ML | Blend of moisturising ingredients | Onco-Cosmeceuticals | Lotion | 1X50 ML | Specially formulated to address Radiation-Induced Dermatitis (RID), affecting nearly 95% of patients undergoing radiation therapy. Its unique blend of ingredients with emollients & humectant that soothes, protects, and heals the skin. |